Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2026-06-16 @ 4:46 PM
Study NCT ID:
NCT04515368
Status:
COMPLETED
Last Update Posted:
2020-09-09
First Post:
2020-08-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity
Sponsor:
Imperial College London
Organization:
Study Overview
Official Title:
A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity
Status:
COMPLETED
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PETVACC
Brief Summary:
This study forms part of an integrated, multi-study effort to identify potential biomarkers of reactogenicity to vaccines. We have selected PET-CT as it is in routine clinical use and has been serendipitously shown to image lymph nodes and injection site inflammation after immunisation.The study's objectives are exploratory:
1. To methodically characterise relative anatomical distribution and intensity of post-immunisation innate immune activation visualised by PET-CT after immunisation with adjuvanted and non-adjuvanted vaccines.
2. To correlate PET/CT changes with diary card recorded symptoms of reactogenicity.
1. To methodically characterise relative anatomical distribution and intensity of post-immunisation innate immune activation visualised by PET-CT after immunisation with adjuvanted and non-adjuvanted vaccines.
2. To correlate PET/CT changes with diary card recorded symptoms of reactogenicity.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: